Uploaded April 2026 | Updated September 2026, 1 week ago
Dr. Andry Levy and his team are working to conduct the first clinical trial using gene therapy to target mutations on the IQSEC2 gene. Learn about animal model outcomes, gene therapy techniques, and considerations for the future in Dr. Levy's recent webinar here: autism.org/gene-therapy-for-mutations-in-the-iqsec2-gene
Dr. Andry Levy and his team are working to conduct the first clinical trial using gene therapy to target mutations on the IQSEC2 gene. Learn about animal model outcomes, gene therapy techniques, and considerations for the future in Dr. Levy's recent webinar here: autism.org/gene-therapy-for-mutations-in-the-iqsec2-gene
